Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation.

Rosenau J, Tillmann HL, Bahr MJ, Trautwein C, Boeker KH, Nashan B, Klempnauer J, Manns MP.

Transplant Proc. 2001 Nov-Dec;33(7-8):3637-8. No abstract available.

PMID:
11750544
2.

Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.

Suehiro T, Shimada M, Kishikawa K, Shimura T, Soejima Y, Yoshizumi T, Hashimoto K, Mochida Y, Maehara Y, Kuwano H.

Liver Int. 2005 Dec;25(6):1169-74.

PMID:
16343068
3.

Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.

Karliova M, Malago M, Trippler M, Valentin-Gamazo C, Rothaar T, Broelsch CE, Gerken G, Treichel U.

Transplant Proc. 2002 Dec;34(8):3319-22. No abstract available.

PMID:
12493460
5.

Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.

Karasu Z, Ozacar T, Akyildiz M, Demirbas T, Arikan C, Kobat A, Akarca U, Ersoz G, Gunsar F, Batur Y, Kilic M, Tokat Y.

Antivir Ther. 2004 Dec;9(6):921-7.

PMID:
15651751
6.

Prevention of de novo hepatitis B virus infections: more seems no better.

Mutimer D.

Liver Transpl. 2010 Mar;16(3):256-8. doi: 10.1002/lt.22026. No abstract available.

7.

Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.

Ben-Ari Z, Mor E, Bar-Nathan N, Shaharabani E, Shapira Z, Tur-Kaspa R.

Transplant Proc. 2003 Mar;35(2):609-11. No abstract available.

PMID:
12644066
8.

Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.

Naoumov NV, Lopes AR, Burra P, Caccamo L, Iemmolo RM, de Man RA, Bassendine M, O'Grady JG, Portmann BC, Anschuetz G, Barrett CA, Williams R, Atkins M.

J Hepatol. 2001 Jun;34(6):888-94.

PMID:
11451173
9.

Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.

Marzano A, Salizzoni M, Debernardi-Venon W, Smedile A, Franchello A, Ciancio A, Gentilcore E, Piantino P, Barbui AM, David E, Negro F, Rizzetto M.

J Hepatol. 2001 Jun;34(6):903-10.

PMID:
11451175
10.

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.

Markowitz JS, Martin P, Conrad AJ, Markmann JF, Seu P, Yersiz H, Goss JA, Schmidt P, Pakrasi A, Artinian L, Murray NG, Imagawa DK, Holt C, Goldstein LI, Stribling R, Busuttil RW.

Hepatology. 1998 Aug;28(2):585-9.

PMID:
9696028
11.

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.

Akyildiz M, Karasu Z, Zeytunlu M, Aydin U, Ozacar T, Kilic M.

J Gastroenterol Hepatol. 2007 Dec;22(12):2130-4.

PMID:
18031370
12.
13.
14.

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.

Yao FY, Osorio RW, Roberts JP, Poordad FF, Briceno MN, Garcia-Kennedy R, Gish RR.

Liver Transpl Surg. 1999 Nov;5(6):491-6.

15.

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.

Tillmann HL, Trautwein C, Bock T, Böker KH, Jäckel E, Glowienka M, Oldhafer K, Bruns I, Gauthier J, Condreay LD, Raab HR, Manns MP.

Hepatology. 1999 Jul;30(1):244-56.

PMID:
10385663
16.

An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.

Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P.

Liver Transpl. 2000 Nov;6(6):741-8.

17.

Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence.

Powell JJ, Apiratpracha W, Partovi N, Erb SR, Scudamore CH, Steinbrecher UP, Buczkowski AK, Chung SW, Yoshida EM.

Clin Transplant. 2006 Jul-Aug;20(4):524-5.

PMID:
16842532
18.
19.

Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.

Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W, Alessandria C, Franchello A, Salizzoni M, Rizzetto M.

Liver Transpl. 2005 Apr;11(4):402-9.

20.

Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study.

Freshwater DA, Dudley T, Cane P, Mutimer DJ.

Transplantation. 2008 Apr 27;85(8):1105-11. doi: 10.1097/TP.0b013e31816a342a.

PMID:
18431229

Supplemental Content

Support Center